The store will not work correctly when cookies are disabled.
6-((10H-phenothiazin-10-yl)methyl)-1,3,5-triazine-2,4-diamine
ID: ALA1098478
PubChem CID: 46888179
Max Phase: Preclinical
Molecular Formula: C16H14N6S
Molecular Weight: 322.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc(N)nc(CN2c3ccccc3Sc3ccccc32)n1
Standard InChI: InChI=1S/C16H14N6S/c17-15-19-14(20-16(18)21-15)9-22-10-5-1-3-7-12(10)23-13-8-4-2-6-11(13)22/h1-8H,9H2,(H4,17,18,19,20,21)
Standard InChI Key: DTHICNGLUJVBSB-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
4.2684 0.2466 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2672 -0.5831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9841 -0.9971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7024 -0.5826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6995 0.2502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9823 0.6604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5505 -0.9961 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9798 1.4876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4195 -0.9951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1352 -0.5804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5672 0.2402 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.1305 0.2421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8491 0.6515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8529 1.4766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1389 1.8934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4195 1.4791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4192 0.6553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5642 -0.5873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8508 -0.9952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8483 -1.8151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5585 -2.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2728 -1.8152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2717 -0.9966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 12 1 0
18 11 1 0
11 13 1 0
5 6 2 0
6 1 1 0
12 13 2 0
1 2 2 0
13 14 1 0
2 7 1 0
14 15 2 0
3 4 2 0
15 16 1 0
6 8 1 0
16 17 2 0
17 12 1 0
4 9 1 0
18 19 2 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 2 0
10 19 1 0
21 22 1 0
2 3 1 0
22 23 2 0
23 18 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 322.40 | Molecular Weight (Monoisotopic): 322.1001 | AlogP: 2.84 | #Rotatable Bonds: 2 |
Polar Surface Area: 93.95 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.69 | CX LogP: 3.57 | CX LogD: 3.56 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.75 | Np Likeness Score: -1.21 |
References
1. Bag S, Tawari NR, Degani MS, Queener SF.. (2010) Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens., 18 (9): [PMID:20363634] [10.1016/j.bmc.2010.03.031] |